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Abstract: 4 
Introduction: Advances in perioperative care have enabled early discharge and outpatient 5 
primary total joint arthroplasty (TJA). However, the safety of early discharge after revision TJA 6 
(rTJA) remains unknown and the COVID-19 pandemic will force decreased hospitalization. This 7 
study compared 90-day outcomes in patients undergoing aseptic rTJA discharged the same or 8 
next day (early) to those discharged two or three days postoperatively (later). 9 
Methods: 530 aseptic rTJAs performed at a single tertiary referral center (12/5/2011-12/30/2019) 10 
were identified. Early and later discharge patients were matched as closely as possible on 11 
procedure type, sex, ASA-PS classification, age, and BMI. All patients were optimized using 12 
modern perioperative protocols. The rate of 90-day ED visits and hospital admissions was 13 
compared between groups. 14 
Results: 183 early discharge rTJAs (54 hips, 129 knees) in 178 patients were matched to 183 15 
later discharge rTJAs (71 hips, 112 knees) in 165 patients. 62% of the sample was female, with 16 
an overall average age and BMI of 63±9.9 (range: 18-92) years and 32±6.9 (range: 18-58) kg/m2. 17 
There was no statistical difference in 90-day ED visit rates between early (6/178, 3.4%) and later 18 
(11/165, 6.7%) discharge patients (p=0.214). 90-day hospital admission rates for early (7/178, 19 
3.9%) and later (4/165, 2.4%) did not differ (p=0.545) 20 
Conclusions: Using modern perioperative protocols and with appropriate patient selection, early 21 
discharge following aseptic rTJA does not increase 90-day readmissions or ED visits. As hospital 22 
inpatient capacity remains limited due to COVID-19, select rTJA patients may discharge home 23 
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the same or next day to preserve hospital beds and resources for more critical medically related 24 
illness. 25 
Keywords: Total joint arthroplasty, Outpatient, Rapid Recovery, Revision, Readmissions, 26 
Complications 27 
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Introduction: 47 
Total joint arthroplasty (TJA) is one of the most successful of orthopaedic procedures [1]. 48 
Historically, multiple days of inpatient care was the expectation following primary TJA. 49 
However, innovations in perioperative care, including surgical technique, pain management, 50 
blood conservation and physical therapy, have enabled rapid recovery and early discharge [2–4]. 51 
Evidence demonstrates early discharge primary TJA (<24 hour stay) to be safe [5–12] and cost 52 
saving [13,14], without increasing readmission rates [15–17]. 53 
Despite the clinical success of primary TJA, complications requiring revision remain a 54 
costly societal burden [18]. As the demand for TJA increases [19], so will the number of 55 
revisions [20]. The most common etiologies leading to revision total hip arthroplasty (rTHA) 56 
include: instability, aseptic loosening and infection [21]. The most common etiologies leading to 57 
revision total knee arthroplasty (rTKA) include: infection, aseptic loosening and instability 58 
[22,23]. Revision TJA traditionally results in longer inpatient lengths of stay (LOS) than primary 59 
TJAs. For example, in a 2009 study the average LOS following the most basic rTHA (head-liner 60 
exchange) was reported as five days and the average LOS for all types of rTHA procedures was 61 
over six days [21]. Similarly, the average LOS for an aseptic rTKA was reported to be over four 62 
days and increased to over five days when infection cases were included [22,23]. 63 
 As surgeons, patients, and institutions become more comfortable with rapid recovery 64 
primary TJA, a natural evolution is to consider subsequently reducing inpatient LOS in the 65 
revision setting as well. Indeed, a goal for better healthcare is to reduce unnecessary waste by 66 
deterring patients and providers from the belief that ‘more is better’ [24,25].  Further, the 67 
COVID-19 pandemic of 2020 has brought to light our somewhat limited healthcare resources 68 
and highlighted our need to preserve inpatient hospital equipment and beds for patients who are 69 
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stricken with severe medical illness.  However, due to increased surgical complexity associated 70 
with revision TJA and the associated physical stress on patients with medical comorbidities, 71 
early discharge after rTJA must be appropriately studied. The primary aim of this study was to 72 
compare 90-day readmission and emergency department (ED) visit rates between patients 73 
undergoing aseptic rTJA discharged the same or next day to those discharged two or more days 74 
postoperatively. Our null hypothesis was that there would be no difference in readmission and 75 
ED visit rates between the two groups. 76 
Methods: 77 
Study Sample:  Five-hundred and thirty unilateral aseptic revision TJAs (rTJA) 78 
consecutively performed between 12/5/2011 and 12/30/2019 were identified in our total 79 
joint arthroplasty registry with institutional review board approval.  All cases were 80 
performed by a single surgeon at a dedicated hip and knee center in a tertiary care 81 
hospital. As shown in Figure 1, 204 (38.5%) rTJAs were discharged on postoperative day 0 82 
or 1 (early discharge TJAs), 316 (59.6%) were discharged on postoperative day 2 or 3 (later 83 
discharge TJAs), and 10 (1.9%) were hospitalized for 4 or more days. The latter cases were 84 
not included in the current study. 85 
Twenty-one (10.3%) of the 204 early discharge rTJAs were excluded as shown in 86 
Table 1 leaving a final analysis sample of 183 index rTJAs.  Table 1 shows that 100 (31.6%) 87 
of the 316 later discharge comparison cases were excluded leaving a pool of 216 cases to 88 
match to the 183 index cases. From this pool, 183 later discharge cases were matched as 89 
closely as possible to early discharge cases on procedure type (rTHA, rTKA), sex, ASA-PS 90 
classification (1 through 4), age (±5 years), and BMI (±5 kg/m2). 91 
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Patient Care Protocols:  As part of our standardized perioperative care program, all patients 92 
underwent preoperative risk assessment and medical clearance within four weeks of surgery by a 93 
medical specialist whose practice focuses exclusively on hip and knee arthroplasty patients. Each 94 
patient’s upcoming surgery was discussed at a coordinated care conference attended by members 95 
of the multidisciplinary team the week prior to their scheduled surgery.  During this meeting, 96 
information is shared across disciplines and patient care plans are proactively developed, which 97 
are shared with everyone who provides direct care or services to the patient.  Preoperatively, 98 
patients and family members received comprehensive clinic-based education and attended a 99 
hospital-based joint replacement class. Postoperatively, all patients were encouraged to ambulate 100 
by the afternoon on the day of surgery when possible and attempts were made to standardize 101 
rehabilitation protocols.  Postoperative care was assumed by the operative surgeon, the internal 102 
medicine specialist, clinic staff, and a multidisciplinary inpatient care team. Postoperative pain 103 
control for the first 24 hours was by an anesthesia pain service.  The same modern perioperative 104 
pain control, clinical, and rehabilitation protocols were used for all patients. 105 
Perioperative and Postoperative Pain Control and Anesthesia Protocols:  A multimodal 106 
preoperative pain protocol was used in all cases. Unless allergic or contraindicated, patients were 107 
given acetaminophen (1000 mg PO) 24 hours before surgery and oxycodone (10 to 20 mg PO), 108 
celecoxib (200 mg PO), and pregabalin (75 mg PO) immediately before surgery.  109 
Intraoperatively, surgeries were performed with standardized light general anesthesia (desflurane 110 
or sevoflurane) and a low-dose intrathecal, single-shot spinal injection of either 0.40 mg of 111 
morphine with a median of 10.5 mg bupivacaine local anesthetic or 25 mcg of fentanyl with a 112 
median of 7.5 mg bupivacaine. Beginning January 1, 2015, the spinal anesthesia medication 113 
cocktail was changed from morphine to fentanyl.  Between September 01, 2012 and May 31, 114 
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2016, patients were instructed not to consume liquids after 12 AM on the day of surgery. 115 
Beginning on June 01, 2016, patients were allowed to drink liquids up to two hours before 116 
surgery. Postoperatively, patients were permitted to drink freely. Patient-specific, goal-directed 117 
fluid therapy called for preoperative, intraoperative, and postoperative administration of 118 
approximately 2000 mL total of crystalloid sodium lactate unless patients had significant renal 119 
diseases in which case normal saline was used. In knees only, a periarticular injection of 0.2% 120 
(200 mg) ropivacaine, 0.5 mg epinephrine, 80 mcg clonidine, and 30 mcg ketorolac (removed for 121 
patients with renal insufficiency) to equal 101.3 mL total volume was used immediately 122 
following final implant fixation.  Postoperatively, unless allergic or contraindicated, patients 123 
received acetaminophen (1000 mg PO tid), OxyContin (10 to 20 mg PO q12 hours), celecoxib 124 
(200 mg PO bid), oxycodone (5-10 mg hourly prn for mild pain and 10-20 mg hourly prn for 125 
moderate pain), or hydromorphone (0.5 mg IV q20 minutes prn for severe pain). IV tranexamic 126 
acid (1 g prior to incision followed by 1 g two hours later) was standardly used. 127 
Thromboprophylaxis was with enteric coated aspirin 81 mg twice daily for six weeks along with 128 
23 hours of sequential compression devices during hospitalization. Those patients at higher risk 129 
for thromboembolism were treated with additional chemoprophylaxis. 130 
Data Analysis:  Data were prospectively recorded in and retrieved from the electronic medical 131 
record (EMR) and verified for accuracy. A retrospective review of the EMR was completed for 132 
each patient. Demographic data including patient age in years, sex (male/female), body mass 133 
index (BMI) in kg/m2, American Society of Anesthesiologists (ASA) physical status 134 
classification (1, 2, 3 or 4), type of procedure (rTHA or rTKA), and reason for revision were 135 
recorded. Details of the procedure were collected and categorized based on the components 136 
revised. Surgical case duration was defined as the length of time, in minutes, from 137 
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procedure start to procedure stop.  Discharge disposition was recorded. All-cause inpatient 138 
readmissions and ED visits were recorded for each patient within 90 days of surgery. For each 139 
readmission or ED visit, date, time, results, and cause for the readmission or visit was recorded.   140 
Minitab 19 (Minitab Inc, State College, PA) was used for data analysis. Continuous data 141 
are reported as means with standard deviations, and categorical data are reported as numbers and 142 
percentages. Means and standard deviations in early and later discharge cases were compared 143 
using Student’s t-test and the Pearson Chi-square test was used to compare categorical 144 
variables.  ED visit and hospital readmission rates in the two groups were compared with the 2-145 
proprtion test using Fishers Exact p value. A critical p value of 0.05 was set for all comparisons.  146 
This research did not receive any specific grant from funding agencies in the public, commercial, 147 
or not-for-profit sectors. 148 
Results: 149 
 Demographic and case characteristics for the two study groups are shown in Table 150 
2.   rTHA was performed in 30% of early discharge and 39% of later discharge patients 151 
(p=0.078). Fifty-eight percent of early discharge and 66% of later discharge patients were 152 
female (p=0.162). The average age (62.6 vs. 64.2 years) and BMI (32.5 vs. 32.3 kg/m2) of 153 
early and later discharge patients, respectively, were not significantly different.  ASA-PS 154 
classification was similarly distributed in the two groups (p=0.094).  Fewer later discharge 155 
patients had private insurance with more of them insured by Medicare (p=0.017). On 156 
average, mean procedure time was 24 minutes longer in later discharge patients (p<0.001).   157 
 Revision etiology for early discharge and later discharge cases is shown separately 158 
for hip and knee procedures in Table 3.  ALTR was the most common reason for rTHA in 159 
early discharge patients whereas loosening was more common in later discharge patients 160 
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(p=0.008). In knees, instability was the most prevalent cause of revision for both early and 161 
later discharge patients (p=0.152).  Components revised in early discharge and later 162 
discharge cases are shown in Table 4.   Revision of both acetabular and femoral 163 
components was most common in early discharge rTHA patients, whereas acetabular 164 
revision alone was more common in later discharge rTHA patients (p<0.001). The majority 165 
of early and later discharge rTKA patients underwent both femoral and tibial component 166 
revision (p=0.063). 167 
One later discharge patient transitioned to a skilled nursing facility.  Among the 168 
remainder of patients, all early discharge patients went home with 75.8% of later discharge 169 
patients going home and 24.2% transitioning to a rehabilitation facility (p<0.001). 170 
Emergency department (ED) visits and hospital admissions within 90 days of aseptic 171 
revision TJA are shown in Table 5.  Six (6/178, 3.4%) early discharge patients and 11 172 
(11/165, 6.7%) later discharge patients presented to the ED (p=0.214).  Complaints ranged 173 
from nausea to shortness of breath and surgical site bleeding, all of which were resolved 174 
without subsequent hospital admission (Table 5).  Three patients in each group (3/178, 175 
1.7% vs. 3/165, 1.8%; p=1.00) presented to the ED and were subsequently admitted to the 176 
hospital (Table 5).  Causes ranged from allergic rash to a pain pump to acute 177 
hematogenous infection in the study joint requiring I&D with component retention. Table 178 
5 also shows that four early discharge patient (4/178, 2.2%) and one later discharge patient 179 
(1/165, 0.06%) were directly admitted to the hospital within 90 days of rTJA (p=0.373). 180 
One of the early discharge patients was admitted for NSTEMI myocardial infarction and 181 
the others required surgical intervention for superficial wound and/or soft tissue repair.  182 
Safety of Early Discharge Revision Total Joint Arthroplasty 
 9
The later discharge patient was directly admitted for acute confusional state with 104° 183 
temperature and evidence of pneumonia. 184 
Discussion: 185 
Over the past decade and a half, there has been a shift from a ‘sick-patient model’ to a 186 
‘well-patient model’ among patients undergoing elective primary TJA, with optimization 187 
occurring prior to surgery and many patients not requiring a prolonged in-hospital stay. An 188 
enhanced understanding of multimodal approaches to pain management, blood conservation and 189 
early mobilization have improved the standardization of care for TJA patients, which has 190 
increased the efficiency of care [5–7,9,26]. Rapid recovery for primary TJA has been 191 
successfully performed in multiple patient populations, with low rates of complications and 192 
readmissions, even among elderly patients [16,27–29]. In its current state, appropriately 193 
performed rapid recovery primary TJA is a safe, [30] cost-efficient, [14,31,32] and patient-194 
friendly strategy [33].  However, there remains disagreement on the optimal inpatient LOS, with 195 
some authors criticizing outpatient TJA as risky and claiming longer inpatient stays allow for the 196 
recognition of life-threatening complications and those complications that prompt readmission 197 
[34,35]. 198 
The exponentially increased demand for TJA has imposed an enormous economic burden 199 
on the healthcare system, accounting for more Medicare expense than any other inpatient 200 
procedure [36]. Not surprisingly, resource utilization and cost containment have become a 201 
primary focus of policy and research on primary and rTJA. Multiple strategies have been 202 
adopted to improve the value of TJA, including a reduction in wasteful spending and a reduction 203 
in hospital LOS [13]. As surgeons, patients, and institutions become more comfortable with rapid 204 
recovery primary TJA, it is likely a similar trend will follow among patients requiring rTJA. To 205 
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prevent an increase in perioperative complications and assure the focus is on patient safety, as 206 
opposed to financial incentives, we sought to determine the safety of a reduced hospital LOS in 207 
aseptic rTJA patients using modern perioperative protocols. The results of this study 208 
demonstrated no significant difference in the 90-day readmission or ED visit rates between 209 
patients undergoing aseptic rTJA discharged on POD zero or one compared to those patients 210 
discharge on POD two or later. These are novel findings, as this is the first paper, to the authors’ 211 
knowledge, that reports on the safety of early discharge revision TJA. 212 
The results of this study are similar to a large database study presented at the 2019 213 
Annual Meeting of the American Academy of Orthopaedic Surgeons by Gu et al, which 214 
analyzed all patients in the American College of Surgeons National Surgical Quality 215 
Improvement Program database who underwent aseptic rTKA and were discharged zero to two 216 
days after the procedure and compared to those discharged three to four days postoperatively 217 
[37].  The authors found no difference in the 30-day complication rate between the two groups.  218 
In contrast to the study by Gu et al, a major strength of the present study is the lack of selection 219 
bias inherent in a large database study. Specifically, all patients included in our study were 220 
exposed to the same modern perioperative protocols. Additionally, a large database study lacks 221 
the appropriate granularity to adjust for institutional protocols or other medical reasons that may 222 
delay discharge following rTKA. Our study utilized matching on multiple potential 223 
confounders, including age, ASA status, gender and BMI to reduce this bias. However, it is 224 
possible uncontrolled variables played a role in the timing of discharge, such as surgical 225 
duration, complexity of the surgery, or other social confounders. Future studies should 226 
investigate these variables further to determine whether a particular combination of 227 
patient and surgical factors decreases the safety of early discharge. Despite not detecting a 228 
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statistically significant difference in ED visit rates between the early and late discharge 229 
rTJA patients, there were 10 more ED visits in the early discharge patients than the late 230 
discharge patients. It is possible we lacked the numbers necessary to detect a statistically 231 
significant difference, representing type-two error. It should be emphasized that the 232 
authors of this study do not interpret the results to mean every aseptic rTJA should be 233 
discharged early. Instead, patients should only be discharged when they are medically and 234 
socially safe for discharge. It appears that when this approach is taken, appropriately 235 
selected aseptic rTJA patients may be discharged early without an increase in 236 
complications. 237 
The results of this study are comparable to those found in investigations of early 238 
discharge after primary TJA. For example, a study conducted at a Veteran’s Affairs hospital 239 
compared patients discharged within one day to more than one day following primary TJA. The 240 
authors reported no significant difference in returns to the operating room, readmissions to the 241 
hospital or visits to the ED [38]. Similarly, in a large database query of 1,220 outpatient primary 242 
TJAs between 2011 and 2014, Maxwell Courtney et al. reported no increased risk of 243 
readmissions or complications [39], a finding that has been reproduced in a number of other 244 
studies [40–42]. Moreover, Feder et al evaluated the safety of 850 same day discharge TJA 245 
patients at a single institution and noted a 90-day readmission rate of 0.94% and a 90-day ED 246 
rate of 1.18% [43]. The higher rates noted in our study can be explained by the findings of 247 
Schairer et al, who showed patients undergoing revision TKA [44] and THA [45] were more 248 
likely to have an unplanned readmission than are patients undergoing a primary TJA. The all-249 
cause 90-day readmission rate in their studies was 8.8% in hips and 13% in knees, which is 250 
higher than the results found in our study. Edwards et al also evaluated the safety of rapid 251 
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recovery TJA, including octogenarians and revisions [46]. Despite a developed clinical 252 
pathway, the authors noted an overall 90-day readmission rate of 15% in THAs and 12% 253 
in TKAs, which are also higher than ours, though direct comparison is limited given the 254 
different patient populations. The lower rates reported in our series may also reflect 255 
differences in our clinical pathway including the multidisciplinary team approach, however 256 
additional research is required to establish this. 257 
 This study is not without limitations, including its retrospective cohort design. Despite 258 
the inherent bias of the study design, all data were prospectively collected on consecutive cases 259 
performed with consistent institutional protocols, which may reduce selection and interpretation 260 
biases. However, it is possible the matching criteria used to match the early and later 261 
discharge patients did not account for potential confounding variables that may have 262 
influenced the results in a way that was not detected statistically.  For example, there were 263 
significantly more private insurance patients in the early discharge group and more 264 
Medicare patients in the later discharge group. Moreover, though not statistically 265 
significant, the case complexity was different between early and late discharge rTHAs. 266 
Specifically, more of the late discharge rTHAs had diagnoses of aseptic loosening and 267 
osteolysis, whereas more of the early discharge rTHAs had ALTR. It is possible the 268 
difference in diagnosis was associated with an increased level of surgical complexity or 269 
bone loss and that this difference was associated with a longer length of stay. Future studies 270 
may seek to evaluate whether increased surgical complexity is associated with longer length 271 
of stay in aseptic rTHA.  Additionally, this study excluded patients undergoing revision for PJI, 272 
in part because none of the infection cases performed during the study period were discharged 273 
early, within POD zero or one. Therefore, this study is not generalizable to the PJI patient 274 
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population. We chose not to include these patients as controls as they are oftentimes more 275 
medically complex, have defined logistical issues related to orchestrating long-term intravenous 276 
antibiotics mandating an extended hospital stay, and have higher unplanned readmission rates 277 
[44,45], which would have introduced significant bias. Future studies should seek to determine 278 
whether a reduction in LOS among patients with PJI has a detrimental effect on outcomes 279 
including readmission rates, complication rates and infection eradication rates. Moreover, it 280 
should be noted that this study only evaluated readmission and ED visit rates and did not 281 
evaluate other outcomes related to patient outcomes following rTJA, like patient reported 282 
outcome measures or long-term success of the implants. Finally, the results of this study are 283 
generalizable, in as much as one is able to adopt the multidisciplinary approach described in the 284 
present study. One part of the multidisciplinary approach is attendance at the joint 285 
replacement class, which is strongly suggested for all revision patients. We did not record 286 
the relative number of participants in each group and this may also represent a source of 287 
confounding and future studies should determine whether this affects discharge timing and 288 
safety in aseptic rTJA. This study demonstrates the feasibility and safety of short stay rTJA, but 289 
also emphasizes the fact that even with a multidisciplinary approach and rapid recovery 290 
protocols, not all revision patients will be safe to undergo early discharge.  291 
In conclusion, this study demonstrates the relative safety of early discharge of aseptic 292 
rTJA patients without an increase in readmission or ED visits within the first 90-days after 293 
surgery. As lengths of stay following rTJA continue to decrease, it is crucial to create evidence-294 
based safeguards to assure focus remains on patient safety to keep the perioperative complication 295 
rates as low as possible. Implementation of a multidisciplinary approach to patient care is 296 
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essential to predicting patient needs in the perioperative period and improves the safety and 297 
feasibility of early discharge patients undergoing aseptic rTJA. 298 
 299 
Table Legends: 300 
Table 1: Early and late discharge revision total joint arthroplasty cases excluded from final 301 
analysis and reasons for exclusion. 302 
Table 2. Comparison of Demographics and Case Characteristics in Early and Later 303 
Discharge Aseptic Revision TJAs 304 
Table 3:  Revision Indications in Early and Later Discharge Aseptic Revision TJAs 305 
Table 4:  Components Revised in Early and Later Discharge Aseptic Revision TJAs 306 
Table 5. 90-Day Emergency Department (ED) Visits and Hospital Admissions in Early and 307 
Later Discharge Aseptic Revision TJAs 308 
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Table 1: Early and late discharge revision total joint arthroplasty cases excluded from final 
analysis and reasons for exclusion. 
Exclusion Reason N (%) Early Discharge Cases 
N (%) 
Later Discharge Cases 
Another Procedure Within a Year 10 (47.6) 27 (27.0) 
Distal Femoral Replacement 0 (0.0) 5 (5.0) 
Extensor Mechanism Repair 2 (9.5) 10 (10.0) 
Heterotopic Ossification Resection 0 (0.0) 2 (2.0) 
Re-Revised 9 (42.9) 56 (56.0) 
Total 21 (100.0) 100 (100.0) 
Table 2. Comparison of Demographics and Case Characteristics in Early and Later 
Discharge Aseptic Revision TJAs 
 
 
Early Discharge 
Cases 
Later Discharge 
Cases p 
N Cases 183 183  
N Patients 178 165  
% Female 57.9 65.6 0.162 
% Male 42.1 34.4  
Mean (SD) Age in 
Years 62.6 (9.5) 64.2 (10.3) 0.132 
Mean (SD) BMI in 
kg/m2 32.5 (7.0) 32.3 (6.8) 0.755 
% rTHA  29.5 38.8 0.078 
% rTKA 70.5 61.2  
ASA-PS 
Classification    
   1 0.5 1.1 0.094 
   2 38.3 33.3  
   3 60.7 61.2  
   4 0.5 4.4  
Insurance Type    
  %  Medicaid 9.8 7.7 0.017 
  %  Medicare 49.0 63.9  
   % Private 40.1 28.4  
Mean (SD) Procedure 
Time in Minutes 111.6 (34.2) 135.7 (48.5) < 0.001 
 
Table 3:  Revision Indications in Early and Later Discharge Aseptic Revision TJAs 
              
Total Early DC Cases Later DC Cases p 
  N % N % N %   
THA REVISIONS 
ALTR 31 24.8% 17 31.5% 14 20.0% 0.008 
Component malposition 5 4.0% 5 9.3% 0 0.0% 
Instability 24 19.2% 13 24.1% 11 15.7% 
Loosening 50 40.0% 16 29.6% 34 48.6% 
Osteolysis/polyethylene Wear 12 9.6% 2 3.7% 10 14.3% 
Other 3 2.4% 1 1.9% 1 1.4% 
Total 125 100.0% 54 100.0% 70 100.0% 
TKA REVISIONS 
Arthrofibrosis 21 8.7% 16 12.4% 5 4.5% 0.152 
Component malposition 3 1.2% 1 0.8% 2 1.8% 
Instability 115 47.7% 65 50.4% 50 44.6% 
Loosening 83 34.4% 37 28.7% 46 41.1% 
Osteolysis/polyethylene Wear 14 5.8% 7 5.4% 7 6.3% 
Other 5 2.1% 3 2.3% 2 1.8% 
Total 241 100.0% 129 100.0% 112 100.0% 
 
 
Table 4:  Components Revised in Early and Later Discharge Aseptic Revision TJAs 
                
Total Early DC Cases Later DC Cases p 
  N % N % N %   
THA REVISIONS 
Both AC and FC 46 36.8% 29 53.7% 17 23.9% <0.001 
AC Only 35 28.0% 4 7.4% 31 43.7% 
FC Only 18 14.4% 5 9.3% 13 18.3% 
Head and Liner Exchange 26 20.8% 16 29.6% 10 14.1% 
Total 125 100.0% 54 100.0% 71 100.0% 
TKA REVISIONS 
Both FC and TC 106 82.2% 103 92.0% 209 86.7% 0.063 
FC Only 8 6.2% 6 5.4% 14 5.8% 
TC Only 3 2.3% 1 0.9% 4 1.7% 
Polyethylene Exchange 12 9.3% 2 1.8% 14 5.8% 
Total 129 100.0% 112 100.0% 241 100.0% 
 
 
 
Table 5. 90-Day Emergency Department (ED) Visits and Hospital Admissions in Early and 
Later Discharge Aseptic Revision TJAs 
 
 Early Discharge Cases Later Discharge Cases 
ED Visit 
Only N = 6 N = 11 
 Cough Weakness, Hypotension, Dehydration 
 Bleeding surgical wound (study joint) Nausea 
 Bilateral lower extremity edema Acute fever normal at presentation 
 Concern for GI bleed, but no bleeding 
found Pain in study joint (3) 
 Study joint dislocation requiring 
closed reduction Shortness of breath (3) 
 Severe headache, resolved DVT 
  Pain medication seeking 
ED followed 
by Inpatient 
Admission 
N = 3 N = 3 
 Acute on chronic CHF exacerbation Non-study joint pain and swelling 
 Acute hematogenous infection of 
study joint treated with I&D and 
component retention 
Study joint superficial wound I&D 
and aspiration 
 Rash reaction to pain pump Nausea, vomiting, abdominal pain, likely from constipation 
Inpatient 
Admission 
Only 
N = 4 N = 1 
 
Study joint superficial wound I&D 
Acute confusional state with 104° 
temperature and evidence of 
pneumonia 
 NSTEMI myocardial infarction  
 Superficial seroma evacuation and 
retinacular defect repair (study joint)  
 Fall with knee dislocation and 
extensor mesh rupture (study joint)  
 
 
 
 

Figure 1. Flowchart of index (LOS 0 to 1) and comparison (LOS 2 to3) cases. 
